- Vienna '18
- ESCRS Player
- On Demand
- ESCRS iLearn
- ESCRS YO's
Session Title: Cataract II
Session Date/Time: Saturday 15/02/2014 | 08:30-11:00
Paper Time: 08:42
Venue: Gallus Hall (Level -1)
First Author: : AntonioToso ITALY
Co Author(s): : Simonetta Morselli
To analyse visual and anatomical results after implantation of INCISE® IOL after 2.0 mm MICS (micro incision cataract surgery)
Ophthalmic Unit S. Bassiano Hospital, Bassano del Grappa (VI), Italy
26 eyes of 26 patients were implanted with Incise™IOL all eyes underwent 2.0 MICS. Data including patients' pre- and postoperative vision. The Incise™(B+L) IOL was implanted with the Viscoject 1.5™inserter using: 1.8mm in the bag. UDVA, CDVA, manifest refraction, predictability of refraction were measured at 1-2 days (V1), 7-15 days (V2), 1-2 months (V3) and 4-6 months (V4) postoperatively. All eyes underwent retro-illuminating fundus camera picture at every post operative examination. Any intra and postoperative complications were recorded.
The mean follow-up period was 6 months. IOL SE power ranged from 18 to 25D. Mean age was 72.0 ±7.5 Years. At V3, mean UDVA was 0.09 ±0.12 logMAR(20/25), mean CDVA was -0.05 ±0.06 logMAR (20/20). Mean Refraction was -0.28 ±0.56. Posterior capsule remained crystal clear after 6 six months. No complications were reported.
Sub 2 mm cataract surgery with implantation of the Incise™IOL is a safe and effective microincision procedure. The lens can be implanted through 1.8 mm in the bag, providing excellent visual and refractive outcomes. Longterm results will be evaluated to assess the posterior capsule opacification FINANCIAL INTEREST: ... travel has been funded, fully or partially, by a company producing, developing or supplying the product or procedure presented